The testosterone conundrum: The putative relationship between testosterone levels and prostate cancer

被引:16
|
作者
Loughlin, Kevin R. [1 ]
机构
[1] Brigham & Womens Hosp, Div Urol, 75 Francis St, Boston, MA 02115 USA
关键词
Testosterone; Prostate cancer; Relationship; ANDROGEN RECEPTOR GENE; AGE-RELATED-CHANGES; SERUM TESTOSTERONE; OLDER MEN; CASTRATION; HORMONE; TISSUE;
D O I
10.1016/j.urolonc.2016.05.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The controversy surrounding the relationship between testosterone and prostate cancer has existed for decades. The literature surrounding this topic is confusing and at times contradictory. There is no level-one quality evidence that confirms or refutes the relationship between either high or low serum testosterone levels and the subsequent development of prostate cancer. This commentary aims to review the issues involved and to provide an interpretation as to the causes of the confusion and to provide a framework for ongoing discussion and investigation. Materials and methods: A Medline and PubMed search was conducted using search terms: testosterone levels and prostate cancer to identify pertinent literature. Results: There is no consistent evidence that a single testosterone level is predictive of prostate cancer risk. Conclusion: The development of prostate cancer is a complex biologic process potentially involving genetics,dietary, life style and hormonal factors. Serum testosterone levels do not accurately reflect the internal prostatic milieu. Finally, if testosterone levels are to be considered in the etiology of prostate cancer they should be measured and interpreted on a chronic basis with multiple measurements over a period of years. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:482.e1 / 482.e4
页数:4
相关论文
共 50 条
  • [41] OBESITY, TESTOSTERONE AND PROSTATE CANCER
    Eufrasio, Pedro
    Parada, Belmiro
    Patrao, Ricardo
    Rolo, Francisco
    Mota, Alfredo
    JOURNAL OF ANDROLOGY, 2009, 30 : 112 - 112
  • [42] Testosterone therapy and prostate cancer
    Pastuszak, Alexander W.
    Rodriguez, Katherine M.
    Nguyen, Taylor M.
    Khera, Mohit
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (06) : 909 - 920
  • [43] Testosterone against prostate cancer?
    Benestad, Haakon B.
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (08) : 749 - 749
  • [44] Serum Testosterone Levels and Prostate Cancer Risk: A Single Post-Hoc Testosterone Measurement is Not Informative
    Loughlin, Kevin R.
    JOURNAL OF UROLOGY, 2019, 201 (01): : 40 - 41
  • [45] RELATIONSHIP OF TESTOSTERONE TREATMENT AND INCIDENT PROSTATE CANCER RISK AMONG US VETERANS WITH LOW SERUM TESTOSTERONE
    Walsh, Thomas
    Shores, Molly
    Smith, Nicholas
    Thompson, Mary Lou
    Fox, Alexandra
    Moore, Kathryn
    Krakauer, Chloe
    Forsberg, Christopher
    Heckbert, Susan
    Matsumoto, Alvin
    JOURNAL OF UROLOGY, 2016, 195 (04): : E28 - E29
  • [46] Testosterone Therapy and Prostate Cancer
    Davidson, Emily
    Morgentaler, Abraham
    UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (02) : 209 - +
  • [47] Testosterone replacement and prostate cancer
    Ramasamy, Ranjith
    Fisher, Erik S.
    Schlegel, Peter N.
    INDIAN JOURNAL OF UROLOGY, 2012, 28 (02) : 123 - 128
  • [48] Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels
    Zhang, Xiao
    Zhong, Yan
    Saad, Farid
    Haider, Karim Sultan
    Haider, Ahmad
    Clendenin, Angela G.
    Xu, Xiaohui
    AGING MALE, 2020, 23 (02): : 112 - 118
  • [49] Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
    Atan, Ali
    Tuncel, Altug
    Yesil, Suleyman
    Balbay, Derya
    ADVANCES IN UROLOGY, 2013, 2013
  • [50] The relationship between serum total testosterone and free testosterone levels with serum hemoglobin and hematocrit levels: a study in 1221 men
    Shin, Yu Seob
    You, Jae Hyung
    Cha, Jai Seong
    Park, Jong Kwan
    AGING MALE, 2016, 19 (04): : 209 - 214